Can Colimix (dicyclomine 20 mg and simethicone 80 mg) be used to treat a gaseous abdomen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Colimix Help with Gaseous Abdomen?

Yes, Colimix (dicyclomine 20 mg + simethicone 80 mg) can help with gaseous abdomen symptoms, primarily through dicyclomine's antispasmodic effects on abdominal pain and bloating, though simethicone's contribution to reducing actual gas volume is questionable.

Dicyclomine Component: Evidence-Based Benefit

The dicyclomine component has demonstrated efficacy for abdominal symptoms in functional bowel disorders. The 2022 AGA guidelines conditionally recommend antispasmodics (including dicyclomine) for IBS patients, showing that antispasmodics provide adequate global relief of symptoms (RR 0.67; 95% CI 0.55-0.80) and improvement in abdominal pain (RR 0.74; 95% CI 0.59-0.93) compared to placebo 1.

Key mechanism: Dicyclomine reduces smooth muscle contraction and possibly visceral hypersensitivity, which addresses the pain and discomfort associated with gaseous distension 1.

Dosing for Dicyclomine

  • Initial dose: 20 mg four times daily
  • May increase to: 40 mg four times daily after one week if tolerated
  • Discontinue if: No efficacy within 2 weeks or side effects require doses below 80 mg/day 2

Simethicone Component: Limited Evidence

The simethicone component shows conflicting and largely negative evidence for actually reducing gas volume:

  • A 1979 double-blind study of 169 patients found no statistically significant difference between simethicone and placebo in reducing gastrointestinal gas on abdominal radiographs 3
  • A 1991 study showed no effect on gastrointestinal symptoms or H2 production from carbohydrate malabsorption 4
  • However, a 2012 meta-analysis found that antispasmodic/simethicone combinations (alverine/simethicone and pinaverium/simethicone) showed improved global symptoms and bloating compared to antispasmodics alone 5

Clinical interpretation: While simethicone may not reduce actual gas volume, the combination formulation showed benefit in clinical trials, possibly through improved symptom perception or other mechanisms.

Practical Recommendations

For symptomatic gaseous abdomen:

  • Start with dicyclomine 20 mg four times daily (the dose in Colimix)
  • Expect improvement in abdominal pain and bloating within 1-2 weeks
  • The combination may provide additional symptomatic benefit over dicyclomine alone, despite simethicone's questionable gas-reducing properties 5

Important Caveats

Anticholinergic side effects are common (61% of patients) 2:

  • Dry mouth (33%)
  • Dizziness (40%)
  • Blurred vision (27%)
  • Nausea (14%)

Avoid in constipation-predominant patients: Regular use may worsen constipation due to anticholinergic effects 1

Never administer dicyclomine intravenously: Risk of thrombosis exists with IV administration 6

Bottom Line

The dicyclomine component provides evidence-based relief for abdominal pain and bloating associated with gaseous distension through antispasmodic action. While simethicone's gas-reducing properties are questionable as monotherapy, the combination formulation has shown clinical benefit in trials. Use the standard 20 mg dicyclomine dose (as in Colimix) four times daily, monitoring for anticholinergic side effects and avoiding use in constipation-predominant patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.